Want to see HK:9886 full AI Analyst Report?
Dingdang Health Technology Group Ltd. (9886) Stock Statistics & Valuation Metrics
Total Valuation
Dingdang Health Technology Group Ltd. has a market cap or net worth of HKD 1.10B. The enterprise value is HKD 199.57M.
- Market Cap
- HKD 1.10B
- Enterprise Value
- HKD 199.57M
Share Statistics
Dingdang Health Technology Group Ltd. has 1,240,312,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,240,312,900
- Owned by Insiders
- ―
- Owned by Institutions
- 0.12%
Financial Efficiency
Dingdang Health Technology Group Ltd.’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -2.71%.
- Return on Equity (ROE)
- -0.03
- Return on Assets (ROA)
- -0.02
- Return on Invested Capital (ROIC)
- -2.71%
- Return on Capital Employed (ROCE)
- -0.03
- Revenue Per Employee
- 2.19M
- Profits Per Employee
- -21.96K
- Employee Count
- 2,232
- Asset Turnover
- 1.72
- Inventory Turnover
- 4.61
Valuation Ratios
The current PE Ratio of Dingdang Health Technology Group Ltd. is -15.49. Dingdang Health Technology Group Ltd.’s PEG ratio is -0.19.
- PE Ratio
- -15.49
- PS Ratio
- 0.19
- PB Ratio
- 0.63
- Price to FCF
- 9.87
- Price to Operating Cash Flow
- 8.21
- PEG Ratio
- -0.19
Income Statement
In the last 12 months, Dingdang Health Technology Group Ltd. had revenue of 4.89B and earned -49.02M in profits. Earnings per share was -0.04.
- Revenue
- 4.89B
- Gross Profit
- 1.72B
- Operating Income
- -53.44M
- Pretax Income
- -30.72M
- Net Income
- -49.02M
- EBITDA
- 87.27M
- Earnings Per Share (EPS)
- -0.04
Cash Flow
In the last 12 months, operating cash flow was 116.64M and capital expenditures -22.17M, giving a free cash flow of 94.47M billion.
- Operating Cash Flow
- 116.64M
- Free Cash Flow
- 94.47M
- Free Cash Flow per Share
- 0.08
Dividends & Yields
Dingdang Health Technology Group Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 10.13%
- Earnings Yield
- -6.44%
Stock Price Statistics
- Beta
- 1.22
- 52-Week Price Change
- -23.08%
- 50-Day Moving Average
- 0.83
- 200-Day Moving Average
- 0.88
- Relative Strength Index (RSI)
- 64.32
- Average Volume (3m)
- 594.76K
Important Dates
Dingdang Health Technology Group Ltd. upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 21, 2026
- Next Earnings Date
- Mar 31, 2027
- Ex-Dividend Date
- ―
Financial Position
Dingdang Health Technology Group Ltd. as a current ratio of 2.28, with Debt / Equity ratio of 16.93%
- Current Ratio
- 2.28
- Quick Ratio
- 1.55
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -2.00
- Interest Coverage Ratio
- -4.32
Taxes
In the past 12 months, Dingdang Health Technology Group Ltd. has paid 21.39M in taxes.
- Income Tax
- 21.39M
- Effective Tax Rate
- -0.70
Enterprise Valuation
Dingdang Health Technology Group Ltd. EV to EBITDA ratio is 1.67, with an EV/FCF ratio of 2.70.
- EV to Sales
- 0.05
- EV to EBITDA
- 1.67
- EV to Free Cash Flow
- 2.70
- EV to Operating Cash Flow
- 2.19
Balance Sheet
Dingdang Health Technology Group Ltd. has HKD 1.13B in cash and marketable securities with HKD 261.79M in debt, giving a net cash position of HKD 866.96M billion.
- Cash & Marketable Securities
- HKD 1.13B
- Total Debt
- HKD 261.79M
- Net Cash
- HKD 866.96M
- Net Cash Per Share
- HKD 0.70
- Tangible Book Value Per Share
- HKD 1.18
Margins
Gross margin is 35.96%, with operating margin of 0.22%, and net profit margin of -1.24%.
- Gross Margin
- 35.96%
- Operating Margin
- 0.22%
- Pretax Margin
- -0.91%
- Net Profit Margin
- -1.24%
- EBITDA Margin
- 3.08%
- EBIT Margin
- 0.22%
Analyst Forecast
The average price target for Dingdang Health Technology Group Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 8.73%
- EPS Growth Forecast
- 80.38%
Scores
- Smart Score
- 4
- AI Score
- 56